UZE:NYE-United States Cellular Preferred 5.500% due 2070 (USD)

COMMON STOCK | |

Last Closing

USD 21.5

Change

+0.03 (+0.14)%

Market Cap

USD 2.74B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TBB AT&T Inc

N/A

USD 151.28B
PRS Prudential Financial Inc

-0.03 (-0.12%)

USD 44.13B
ALL-PB The Allstate Corporation

-0.02 (-0.08%)

USD 33.97B
SOJC Southern Co

+0.02 (+0.06%)

USD 24.81B
AIZN Assurant Inc

+0.10 (+0.44%)

USD 9.38B
RZB Reinsurance Group of America I..

+0.06 (+0.24%)

USD 8.79B
PCG-PA Pacific Gas and Electric Compa..

-0.14 (-0.55%)

USD 6.52B
PCG-PB Pacific Gas and Electric Compa..

N/A

USD 5.89B
UNMA Unum Group

-0.07 (-0.27%)

USD 5.82B
PCG-PD Pacific Gas and Electric Compa..

+0.22 (+1.08%)

USD 5.34B

ETFs Containing UZE

PFFA Virtus InfraCap U.S. Pref.. 1.03 % 2.13 %

+0.06 (+0.27%)

USD 1.25B
FPE First Trust Preferred Sec.. 0.44 % 0.85 %

+0.03 (+0.27%)

USD 5.50B

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.45% N/A N/A 84% B
Dividend Return 3.85% N/A N/A 70% C-
Total Return 24.30% N/A N/A 86% B+
Trailing 12 Months  
Capital Gain 30.38% N/A N/A 84% B
Dividend Return 6.25% N/A N/A 77% C+
Total Return 36.64% N/A N/A 87% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -6.16% N/A N/A 13% F
Dividend Return -2.21% N/A N/A 15% F
Total Return 3.95% N/A N/A 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 23.04% N/A N/A 45% F
Risk Adjusted Return -9.60% N/A N/A 19% F
Market Capitalization 2.74B N/A N/A 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike